Latest Lead News

Microba Life Sciences reveals preliminary data from over 4,600 MetaXplore GI Plus tests showing significant clinical findings in the majority of patients, with two-thirds reporting symptom improvements following test-guided care.

Nimy Resources has launched a Phase 2 drilling campaign at its promising Block 3 Gallium project in Western Australia, aiming to expand known mineralisation and progress towards a maiden JORC resource. The program also supports metallurgical testing critical to commercial development.

QBE Insurance Group has announced plans to issue AUD subordinated notes as part of its capital management strategy, aiming to strengthen its Tier 2 capital base. Details on pricing and timing will follow, contingent on market conditions.

Anteris Technologies Global Corp. reported a $21.9 million net loss for Q1 2025, driven by increased R&D spending as it scales manufacturing and prepares pivotal trials for its DurAVR Transcatheter Heart Valve. The company’s recent $80 million IPO proceeds are being deployed to support these efforts and repay debt.

Lindian Resources reports strong progress on its Kangankunde Rare Earths Project in Malawi, securing multiple financing proposals and advancing construction ahead of schedule. The company targets production in 2026 amid growing global demand for critical minerals.

Strickland Metals is advancing its 7.4 million ounce Rogozna Gold and Base Metals Project in Serbia through expanded development studies, community engagement, and key management appointments. The company targets a scoping study release by year-end 2025.

Insignia Financial updates the market on its acquisition talks, revealing Bain Capital's withdrawal due to global market volatility while discussions with CC Capital continue without certainty.

Sarama Resources reported a $673,644 net loss in Q1 2025 while progressing exploration in Western Australia and initiating a $120 million arbitration over a disputed Burkina Faso permit withdrawal.

Green Critical Minerals confirms the materiality of a formal sample request from a leading European thermal management provider, underscoring growing market interest in its VHD Graphite technology.

Nanoveu Limited has increased its capital raise by $310,000, bringing the total placement to $3.02 million, with updated details on share and option issuances including conditional allocations to its Executive Chairman.

Neuren Pharmaceuticals has received official FDA minutes confirming the primary endpoints for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, reinforcing the positive signals from earlier studies.

Ava Risk Group has landed a $0.9 million contract to deploy its advanced fibre sensing technology along a critical 1,104km gas pipeline in India, reinforcing its role in safeguarding vital energy infrastructure.